Group One Trading
ANIX icon

Group One Trading’s Anixa Biosciences ANIX Stock Holding History

Group One Trading’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.42K Sell
2,100
-2,600
-55% -$7.7K ﹤0.01% 6675
2025
Q4 		$14.7K Buy
4,700
+2,100
+81% +$8.6K ﹤0.01% 6577
2025
Q3 		$8.58K Buy
2,600
+1,600
+160% +$5.06K ﹤0.01% 7266
2025
Q2 		$3.3K Sell
1,000
-300
-23% -$857 ﹤0.01% 7244
2025
Q1 		$3.72K Buy
+1,300
New +$3.72K ﹤0.01% 6770
2024
Q4 		– Sell
-800
Closed -$2.52K – 7218
2024
Q3 		$2.52K Buy
+800
New +$2.46K ﹤0.01% 6086
2024
Q1 		– Sell
-2,500
Closed -$9.7K – 6985
2023
Q4 		$9.7K Buy
+2,500
New +$8.43K ﹤0.01% 6225
2023
Q3 		– Sell
-6,900
Closed -$22.1K – 7604
2023
Q2 		$22.1K Buy
+6,900
New +$26.6K ﹤0.01% 5935
2022
Q1 		– Sell
-1,100
Closed -$3K – 7972
2021
Q4 		$3K Buy
+1,100
New +$4.45K ﹤0.01% 7756

Other funds holding ANIX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Group One Trading's ANIX Position: Q4 2025 in Review

Group One Trading sold out of Anixa Biosciences (ANIX) in Q4 2025, closing a stake of 4,832 shares — an estimated $19.8K sold.

Group One Trading first reported a position in ANIX in Q2 2023 and held it in 8 quarters. The position peaked at $60K in Q3 2024. 71 funds tracked by Wall St. Rank hold ANIX as of Q4 2025.

  • Group One Trading reported no remaining Anixa Biosciences position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 4,832 Anixa Biosciences shares in Q4 2025, an estimated $19.8K.
  • Group One Trading first reported a position in Anixa Biosciences in Q2 2023 and held it in 8 quarters.
  • Group One Trading's Anixa Biosciences position peaked at $60K in Q3 2024.
  • 71 funds tracked by Wall St. Rank held Anixa Biosciences as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.